Login / Signup

Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin.

Reinier SmitRob J van MarumNathalie C PéquériauxDaan A HollanderMichiel W P BleekerYasamin LatifyWalter A HermensHieronymus J Derijks
Published in: European journal of clinical pharmacology (2017)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • risk factors